Live Price
Live Volume
Summit Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
| Open | $16.03 |
|---|---|
| Close | $15.98 |
| Low | $15.71 |
| Low Change | -0.32 (-2.00%) |
| High | $16.11 |
| High Change | +0.08 (+0.50%) |
| Range | $0.40 |
| Volume | 408.817K |
| Dollar Volume | $6.53M |
Regular Trading Hours
| Open | $16.03 |
|---|---|
| Close | $16.03 |
| Low | $15.57 |
| Low Change | -0.47 (-2.90%) |
| High | $16.43 |
| High Change | +0.40 (+2.50%) |
| Range | $0.87 |
| Volume | 3.065M |
| Dollar Volume | $49.11M |
Premarket
| Open | $16.08 |
|---|---|
| Close | $16.08 |
| Low | $15.91 |
| Low Change | -0.17 (-1.06%) |
| High | $16.15 |
| High Change | +0.07 (+0.44%) |
| Range | $0.24 |
| Volume | 32.294K |
| Dollar Volume | $519.29K |
After Hours Yesterday
| Open | $16.20 |
|---|---|
| Close | $16.25 |
| Low | $15.91 |
| Low Change | -0.29 (-1.79%) |
| High | $16.25 |
| High Change | +0.05 (+0.33%) |
| Range | $0.34 |
| Volume | 404.218K |
| Dollar Volume | $6.57M |
Regular Trading Hours Yesterday
| Open | $15.74 |
|---|---|
| Close | $16.20 |
| Low | $15.74 |
| Low Change | 0.00 (0.00%) |
| High | $16.55 |
| High Change | +0.81 (+5.14%) |
| Range | $0.81 |
| Volume | 3.989M |
| Dollar Volume | $64.62M |
Premarket Yesterday
| Open | $15.64 |
|---|---|
| Close | $15.70 |
| Low | $15.44 |
| Low Change | -0.20 (-1.31%) |
| High | $15.72 |
| High Change | +0.08 (+0.51%) |
| Range | $0.28 |
| Volume | 20.042K |
| Dollar Volume | $314.66K |
Summit Therapeutics News
1 month agoinvesting.comWhy is Summit Therapeutics stock surging today?
1 month agobarrons.comAMD, Nvidia, Navitas, Summit Therapeutics, Fair Isaac, and More Stocks That Explain Today’s Market
1 month agobloomberg.comSummit Therapeutics Jumps on $2 Billion AstraZeneca Investment
2 months agoinvesting.comSummit Therapeutics stock surges on Jefferies upgrade to buy
2 months agoinvesting.comSummit Therapeutics stock rises on positive survival data
2 months agoinvesting.comWhy is Summit Therapeutics stock surging today?
2 months agoinvesting.comSummit Therapeutics stock jumps on partner’s cancer trial data
2 months agoinvesting.comWhy is Summit Therapeutics stock climbing today?
3 months agoinvesting.comSummit Therapeutics stock rises on positive cancer trial data
5 months agoinvesting.comSummit Therapeutics stock rises after CEO share purchase
Summit Therapeutics Top Trades
Summit Therapeutics's top trade so far today returned +3.50%, while the top short trade returned -4.38%.
Summit Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $15.46 |
|---|---|
| 10 Day Moving Average (SMA10) | $15.50 |
| 20 Day Moving Average (SMA20) | $16.11 |
| 50 Day Moving Average (SMA50) | $15.99 |
| 100 Day Moving Average (SMA100) | $15.06 |
| 200 Day Moving Average (SMA200) | $16.18 |
Summit Therapeutics Statistics
| Average Volume (30 Days) | 7.08M |
|---|---|
| P/E Ratio (Current) | -16.44 |
| EPS (Current) | -$1.07 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$459.82M |
| Cash Ratio | 4.05 |
| Current Ratio | 6.96 |
| Quick Ratio | 6.96 |
| Debt to Equity | 0.00 |
| Enterprise Value | $13.61B |
| EV to EBITDA | -15.56 |
| EV to Sales | — |
| Price to Book | 22.27 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.14% |
| Return on Equity | -1.36% |
Summit Therapeutics Stock Splits
There have been no stock splits for Summit Therapeutics (SMMT).
Summit Therapeutics Dividends
There have been no dividends for Summit Therapeutics (SMMT).